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Analysis of CRISPR in Streptococcus mutans suggests frequent
occurrence of acquired immunity against infection by M102-like
bacteriophages
Abstract
Clustered regularly interspaced short palindromic repeats (CRISPR) consist of highly conserved direct
repeats interspersed with variable spacer sequences. They can protect bacteria against invasion by
foreign DNA elements. The genome sequence of Streptococcus mutans strain UA159 contains two
CRISPR loci, designated CRISPR1 and CRISPR2. The aims of this study were to analyse the
organization of CRISPR in further S. mutans strains and to investigate the importance of CRISPR in
acquired immunity to M102-like phages. The sequences of CRISPR1 and CRISPR2 arrays were
determined for 29 S. mutans strains from different persons. More than half of the CRISPR1 spacers and
about 35 % of the CRISPR2 spacers showed sequence similarity with the genome sequence of M102, a
virulent siphophage specific for S. mutans. Although only a few spacers matched the phage sequence
completely, most of the mismatches had no effect on the amino acid sequences of the phage-encoded
proteins. The results suggest that S. mutans is often attacked by M102-like bacteriophages, and that its
acquisition of novel phage-derived CRISPR sequences goes along with the presence of S. mutans
phages in the environment. Analysis of CRISPR1 of M102-resistant mutants of S. mutans OMZ 381
showed that some of them had acquired novel spacers, and the sequences of all but one of these matched
the phage M102 genome sequence. This suggests that the acquisition of the spacers contributed to the
resistance against phage infection. However, since not all resistant mutants had new spacers, and since
the removal of the CRISPR1 array in one of the mutants and in wild-type strains did not lead to loss of
resistance to infection by M102, the acquisition of resistance must be based on further elements as well.
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Summary 
Clustered regularly interspaced short palindromic repeats (CRISPR) consist of highly 
conserved direct repeats interspersed with variable spacer sequences. They can 
protect bacteria against invasion by foreign DNA elements. The genome sequence of 
Streptococcus mutans strain UA159 contains two CRISPR loci, designated CRISPR1 
and CRISPR2. The aims of this study were to analyze the organization of CRISPR in 
further S. mutans strains and to investigate the importance of CRISPR in acquired 
immunity to M102-like phages. The sequences of CRISPR1 and CRISPR2 arrays 
were determined for 29 S. mutans strains from different persons. More than half of 
the CRISPR1 spacers and about 35% of the CRISPR2 spacers showed sequence 
similarity with the genome sequence of M102, a virulent siphophage specific for S. 
mutans. Although only few spacers matched the phage sequence completely, most 
of the mismatches had no effect on the amino acid sequences of the phage-encoded 
proteins. The results suggest that S. mutans is often attacked by M102-like 
bacteriophages, and that its acquisition of novel-phage derived CRISPR sequences 
goes along with the presence of S. mutans phages in the environment. Analysis of 
CRISPR1 of M102-resistant mutants of S. mutans OMZ 381 showed that some of 
them had acquired novel spacers and the sequences of all but one of these matched 
the phage M102 genome sequence. This suggests that the acquisition of the spacers 
contributed to the resistance against phage infection. However, since not all resistant 
mutants had new spacers, and since the removal of the CRISPR1 array in one of the 
mutants and in wild-type strains did not lead to loss of resistance to infection by 
M102, the acquisition of resistance must be based on further elements as well.  
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Introduction 
The human oral cavity is inhabited by more than 500 different bacterial 
species (Paster et al., 2001), of which only a few cause disease. Dental caries, one 
of the most frequent diseases in humans, is caused by microorganisms that 
metabolize dietary sugars into acids. The concomitant decrease in pH results in 
demineralization of the hard tissues of teeth. Mutans streptococci, in particular 
Streptococcus mutans, are considered the principal etiological agents of dental 
caries. Most efforts to develop strategies for prevention of this disease are therefore 
aimed towards reduction of S. mutans by interference with colonization or by passive 
or active immunization while leaving beneficial microorganisms untouched. Phage 
therapy, the application of bacteriophages to combat bacterial infections, has 
regained interest during the last several years due to the increase of bacterial 
resistance to conventional antibiotics. In principle, phage therapy could be used to 
specifically remove S. mutans from dental plaque. 
Relatively little is known about S. mutans bacteriophages and about the role 
they play in the ecology of S. mutans in the oral cavity. It is difficult to isolate 
bacteriophages specific for mutans streptococci (Bachrach et al., 2003; J. R. van der 
Ploeg, unpublished results). Armau et al. (1988) isolated 16 lytic bacteriophages 
specific for strains of S. mutans and Streptococcus sobrinus by screening more than 
1000 plaque samples. Three of these, phages M102, e1 and f2, appeared similar, as 
suggested by comparable virion sizes, GC content, DNA-DNA hybridization, and 
restriction fragment analysis, although the phages showed different serotype 
specificity (Delisle & Rostkowski, 1993). The genome sequence of M102, which is 
specific for S. mutans serotype c strains, has been determined (van der Ploeg, 
2007). Another serotype c specific bacteriophage, M101, appears closely related to 
M102 (van der Ploeg, 2007).  
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One of the weaknesses of phage therapy is the eventual development of 
resistance against bacteriophage infection. S. mutans strain OMZ 381 is one of only 
few strains supporting propagation of M102 (Delisle & Rostkowski, 1993; J. R. van 
der Ploeg, unpublished results). The causes for this limited host range are not 
known. Several mechanisms that render lactic acid bacteria resistant to phage 
infection have been described: Inhibition of phage adsorption, inhibition of DNA 
injection, restriction modification of phage DNA, and abortive infection (Forde & 
Fitzgerald, 1999). In the case of S. mutans nothing is known about the latter three 
mechanisms, but it has been shown that M102 does adsorb also to S. mutans 
serotype c strains that do not support propagation (Shibata et al., 2009). This 
suggests that factors different from phage adsorption must determine resistance of S. 
mutans serotype c strains to infection by M102.  
Recently, a novel phage resistance mechanism, which relies on Clustered 
Regularly Interspaced Short Palindromic Repeats (CRISPR) and a set of CRISPR-
associated genes (cas), has been discovered (Barrangou et al., 2007). CRISPR 
clusters consist of direct repeats of 24-47 bp, which are separated by unique spacers 
of 25-72 bp (Makarova et al., 2006; Sorek et al., 2007). Several CRISPR subtypes 
exist and each subtype has its own particular set of cas genes (Kunin et al., 2007). 
CRISPRs are found in about 40% of sequenced bacterial genomes and in about 90% 
of sequenced archaeal genomes (Sorek et al., 2007). Frequently, a high number of 
the CRISPR spacer sequences show homology to bacteriophage or plasmid 
sequences. It was shown that Streptococcus thermophilus mutants with acquired 
resistance to phage infection had incorporated an additional CRISPR spacer, whose 
sequence matched 100 % with part of the phage genome (Barrangou et al., 2007). 
Removal of this spacer sequence led to sensitivity to phage infection (Barrangou et 
al., 2007). Apart from providing resistance to bacteriophages, CRISPR interference 
 5
was also shown to block plasmid DNA conjugation and transformation (Marraffini & 
Sontheimer, 2008). 
In the present study, the incidence and the composition of CRISPR in S. 
mutans and other mutans streptococci was examined and the role of CRISPR in 
protection against bacteriophage infection was investigated. 
 
 
Materials and Methods 
 
Strains, plasmids and phages and growth conditions 
S. mutans strains used are listed in Table 1. Unless specified otherwise, they were 
routinely grown at 37 °C under anaerobic conditions  or in an atmosphere of 10 % 
CO2 and 90 % air in THY medium, which consists of Todd-Hewitt (Beckton-
Dickinson) with 0.3 % yeast extract (Oxoid). Solid medium contained 1.5 % agar. 
Bacteriophages M102 and M101 were propagated in S. mutans strain OMZ 381 as 
described (van der Ploeg, 2007). When required, erythromycin was added to a final 
concentration of 10 µg ml-1. Escherichia coli JM109 was used as host for propagation 
of plasmids and grown in LB medium at 37 °C with ae ration. When required, 
erythromycin was added to a final concentration of 200 µg ml-1. 
 
PCR amplification and DNA sequencing 
Chromosomal DNA was isolated with a GenElute bacterial genomic DNA kit (Sigma). 
CRISPR1 arrays were amplified by PCR with primers CRu and CRd or Cru2 and 
Crd2 (Supplementary Table S1). For amplification of CRISPR2 arrays, primers Cau 
and Cad, or Cau2 and Cad2 were used. Taq DNA polymerase (New England 
Biolabs) or Jumpstart Taq polymerase (Sigma) were employed. The PCR program 
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consisted of an initial denaturation for 3 min at 95 °C, followed by 30 cycles of 
annealing for 30 s at 55 °C, extension for 3 min at  72 °C and denaturation for 30 s at 
95 °C. PCR products were purified with a Jetquick P CR purification kit (Genomed) 
and directly sequenced using dye-terminator technology (Microsynth) with one of the 
primers used for amplification. When required, a primer walking strategy was 
employed for the sequencing of large CRISPR arrays. 
The serotype of S. mutans strains OMZ 380, OMZ 382, OMZ 737, and 
OM1079 was determined by PCR analysis (Shibata et al., 2003). In addition, spaP, 
atlA, SMU.1757c, or SMU.1762c from some strains were amplified by PCR with 
primers listed in the Supplementary Table S1 and sequenced with one of the primers 
used for amplification. Specific fragments of bacteriophage M101 were amplified and 
sequenced using primers specified in Supplementary Table S1.  
 
Bioinformatic analyses 
CRISPR spacers were identified by using the CRISPR finder tool (available at 
http://crispr.u-psud.fr/; Grissa et al., 2007) combined with visual inspection of the 
sequence. Similarity of spacers to M102 was analyzed by tblastx (using 0.1 as e-
value cut off). Similarity between spacer and database sequences was searched for 
by blast analysis. Weblogo (Crooks et al., 2004) was used to visualize sequence 
consensus motifs. 
 
Isolation of mutants resistant to infection by phage M102 
S. mutans strain OMZ 381 is one of a few strains which support propagation of 
bacteriophage M102 (Delisle & Rostkowski, 1993; Shibata et al., 2009). Strain OMZ 
381 was therefore chosen to isolate phage-resistant mutants. For this, 100 µl of serial 
dilutions of an exponentially growing OMZ 381 culture were mixed with about 3x108 
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pfu of phage M102. After incubation at 37 °C for 30  min, 4 ml of M1D soft agar (van 
der Ploeg, 2007) were added, immediately poured on a M1D plate and incubated for 
48 h at 37 °C. Colonies that appeared were recloned  on M1D agar and tested for 
resistance to phage infection. 
One further M102-resistant mutant was isolated in the course of an animal 
experiment. In brief, in a study approved by the “Veterinäramt des Kantons Zürich” 
and conformed to the Swiss laws on animal protection, ten specific-pathogen-free, 
caries-susceptible Osborne-Mendel rats (Institute of Oral Biology, University of 
Zurich, Zurich, Switzerland) were associated orally with S. mutans OMZ 381 as 
described (Thurnheer et al., 2008). Thereafter, phage M102 (105 pfu, 0.1 ml) was 
applied in the oral cavity of the rats (twice daily on days 23, 24, 25 and 26). Oral 
swabs were taken from all rats on days 29, 34 and 43, suspended in 0.9 % NaCl and 
various dilutions were plated on S. mutans selective medium. Three S. mutans 
colonies from each rat were tested for resistance to phage M102. Only two mutants 
were obtained, both from day 43, of which one, OMZ 432, was used for further 
investigation. 
 
Construction of mutations in CRISPR1 and SMU.1405c  
For construction of mutants with a deletion in CRISPR1, a double-crossover 
replacement strategy was employed. The region 5’ to CRISPR1 was amplified by 
PCR with primers CR1 and CR2, using genomic DNA from S. mutans OMZ 1001 as 
template (OMZ 1001 is a derivative of UA159 with high transformation frequency). 
The product was digested with BamHI and HindIII and cloned into plasmid pFW15 
(Podbielski et al., 1996) to create plasmid pOMZ357. Subsequently, the region 3’ to 
CRISPR1 was amplified with primers CR3 and CR4, digested with EcoRI and NcoI, 
and cloned into pOMZ357 to create pOMZ358. Plasmid pOMZ358 was linearized by 
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digestion with BamHI and introduced into S. mutans strains by transformation of 
naturally competent cells (Perry & Kuramitsu, 1981). Selection for chromosomal 
integration was done on THY agar plates containing erythromycin. Correct integration 
was confirmed by PCR analysis. 
A similar strategy was used for the construction of SMU.1405c knock-out 
mutants. An approximately 500 bp fragment internal to SMU.1405c was amplified by 
PCR with primers 1405c1 and 1405c2. The fragment was digested with BamHI and 
HindIII and cloned into pFW15 to give plasmid pOMZ417. A second fragment 
harbouring the 3’ end of SMU.1405c was amplified with primers 1405c3 and 1405c4, 
digested with PstI and EcoRI and cloned into pOMZ417 to yield plasmid pOMZ418. 
The EcoRI linearized plasmid pOMZ418 was introduced into different strains of S. 
mutans by transformation. Selection for and confirmation of plasmid integration was 
done as described above. 
 
 
Results  
 
Bioinformatic analysis of CRISPR arrays and cas genes in S. mutans UA159 
The annotated genome of S. mutans UA159 (Ajdić et al., 2002) was found to 
harbour two CRISPR loci, designated CRISPR1 and CRISPR2. Two S. mutans 
CRISPR types have also been identified recently by others (Haft et al., 2005; Horvath 
et al., 2008a). As outlined in Fig. 1A, CRISPR1 is located between open reading 
frames (ORF) SMU.1400 and SMU.1398 and contains six identical copies of a 
partially palindromic sequence of 36 bp (5’-
GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC-3’). A seventh degenerated 
repeat with 67% identity (5’-GTTTTAGAGCCATGTTAGTTACTGATTTACTAAAAT-
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3’) is located proximal to SMU.1398. All repeats are interspersed by spacers of 30 bp 
in size. The CRISPR1 array is preceded by four open reading frames (SMU.1405c, 
SMU.1404c, SMU.1403c and SMU.1402c) whose amino acid sequences show 
similarity to those of cas genes of the Nmeni subtype (Haft et al., 2005). This subtype 
is usually associated with the CRISPR repeat cluster 10 (Kunin et al., 2007), to which 
the S. mutans CRISPR1 repeat also belongs. An additional partially homologous 
repeat (5’-TTTAACTTGCTGTGTTGTTTCGAATGATTCCAACAC-3’) is present 
upstream of SMU.1405c (Fig. 1), which is a common feature of this CAS/CRISPR 
subtype (Haft et al., 2005). Another annotated ORF, SMU.1399, overlaps with the 
CRISPR1 array (not shown). Its deduced amino acid sequence shows no similarity to 
proteins of known function.  
The CRISPR2 locus of UA159 is located between SMU.1753c and 
SMU.1752c and consists of two 32 bp partially homologous repeats (5’- 
GTCGCACCCTTCACGGGTGCGTGGATTGAAAT-3’ and 5’- 
GTCGCACCCTTTAAAGGTTGGGTTTGCTTTTT-3’), separated by a 34 bp spacer 
(Fig. 1B). The first repeat is identical to a CRISPR repeat present in the genome of 
Streptococcus pyogenes M49 (McShan et al., 2008). It is a member of repeat cluster 
3 (Kunin et al., 2007), associated with subtype Dvulg cas genes (Haft et al., 2005). 
The black labelled genes from SMU.1764c to SMU.1753c located upstream of the 
first repeat (Fig. 1) belong to this subtype. However, two of these appear to be 
truncated through a frame shift mutation genes (csd1 and cas1) and a premature 
stop codon (cas1). 
 
Distribution of CRISPR1 and CRISPR2 in mutans streptococci 
The distribution of CRISPR1 and CRISPR2 in 29 isolates of S. mutans (Table 
1) was investigated by PCR analysis and sequencing, using primers derived from the 
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sequences bordering the CRISPRs of S. mutans UA159. Since it turned out that 
strains OMZ 186, OMZ 949 and OMZ 961 contained identical CRISPRS (see below), 
OMZ 949 and OMZ 961 were omitted from the analysis. CRISPR1 was detected 
more frequently (in 19 out of 27 strains) than CRISPR2 (9 out of 27). In only 4 strains 
(OMZ 7, UA159, OMZ 67 and OM98x), both CRISPR clusters were present. Three 
serotype c strains yielded neither a CRISPR1 nor a CRISPR2 PCR product. Most 
positive strains displayed many more repeats and spacers in both CRISPR1 and 
CRISPR2 than S. mutans UA159 (Fig. 2A and 2B). 
A total of 305 CRISPR1 spacers were found in the 19 strains that yielded a 
PCR product, the mean number was 16.0 (range 3-38; Supplementary Table S2). 
Within CRISPR2 155 spacers were found in 9 positive strains with a mean number 
17.2 spacers per strain (range 1-50).  
 
Sequence analysis of CRISPR1 and CRISPR2 spacers and repeats 
Spacers: 
More than 90% of the CRISPR1 spacer sequences were 30 bp in size, the 
remaining spacers consisted of 28, 29 or 31 bp (Supplementary Table S2). Most 
were unique, only the terminal spacer (preceding the terminal degenerated repeat) 
showed some conservation. A total of six different terminal spacers was found, of 
which one occurred in eight different strains. Apart from the conservation of the last 
spacer, there were only eight identical CRISPR1 spacer pairs and these pairs were 
always located close to each other within a single strain. A peculiarity was CRISPR1 
from OM98x with a block of three spacers in repeat. These duplications may have 
been selected in response to phage predation as they could lead to an increased 
efficiency of inhibition of the target nucleic acid. Alternatively, identical spacers could 
have been generated by errors of the CRISPR machinery.  
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With respect to CRISPR2 spacers, sequences of 34 bp occurred most 
frequently, followed by 35, 33 and 36 bp (Supplementary Table S3). As for CRISPR1, 
identical spacers were detected only occasionally. An exception was again the 
terminal spacer sequence, which occurred in three variants.  
Repeats: 
 The sequences of the CRISPR1 and CRISPR2 repeats are summarized in 
Supplementary Tables S4 and S5, respectively. In contrast to spacer diversity, no 
sequence variation was found in the CRISPR repeats, except for the terminal repeat 
which was found in three variants. In all strains, except for MT4963, the last residue 
of the terminal repeat was either C or T. Regular CRISPR2 repeats occurred in two 
variants, with only one base pair being affected. The terminal repeat was different 
from the regular repeats and also occurred in two variants.  
 
Inactive CRISPR2 in UA159 due to mutations 
As described above, cas1 and csd1, which are associated with CRISPR2, appeared 
to be truncated in UA159. Since this strain contains only one CRISPR2 spacer, it has 
been postulated that the mutations in cas1 and csd1 render the CRISPR2 system 
inactive (Horvath et al., 2008a). To find evidence for this hypothesis, part of the cas1 
gene (861 bp) from strains OMZ 960 and OM98x were sequenced. The data show 
that these strains contain 13 and 33 CRISPR2 spacers respectively, which suggests 
an active CRISPR2 system. Compared with the sequence of UA159, two base pairs 
(GT) are inserted in both OMZ 960 and OM98x (Supplementary Figure S1). In 
addition, the stop codon present in the UA159 sequence is absent in OMZ 960 and 
OM98x.  
Likewise, part of the sequence of csd1 (660 bp) from OMZ 960 was 
determined. Comparison with UA159 revealed two differences: an A-G transition, 
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which has no influence on the amino acid sequence of the encoded protein and an 
insertion of one bp within a homopolymeric dA tract in the UA159 sequence, which 
results in a frame shift (data not shown). Together, these results suggest that both 
cas1 and csd1 are non-functional in UA159, probably implying that UA159 has lost 
the ability to incorporate novel CRISPR2 spacers.  
 
Identical CRISPR1 sequences in OMZ 186 and OMZ 961 
The CRISPR1 sequences of OMZ 961 (NG8, obtained from G. Spatafora) and OMZ 
186 (KSPK2 or JC-2) were identical. This appeared rather unlikely, since the strains 
had been isolated in New Guinea and Sweden respectively (R. Russell, personal 
communication). Hence, the CRISPR1 sequence of OMZ 949 (NG8, obtained from 
D. Cvitkovitch) was determined as well and found to be identical to CRISPR1 from 
OMZ 961 and OMZ 186. To investigate this further, a part of the sequence of the 
spaP gene of these three strains was determined, since it had been reported that 
spaP is different in KSKP2 and NG8 (Demuth et al., 1990; Paula Crowley, personal 
communication). However, in the present study the spaP sequences obtained from 
OMZ 961 and OMZ 186 were identical to KSPK2 (data not shown), which strongly 
suggests that some laboratories hold the same strain under different names. 
 
Similarity of CRISPR spacers to bacteriophage M102  
Of the 305 CRISPR1 spacer sequences determined, only five matched the 
bacteriophage M102 genome sequence exactly. However, 164 CRISPR1 spacers 
showed sequence similarity to M102 (more than 17 identical residues; Fig. 2A). The 
majority of them contained mismatches at degenerate positions, and the encoded 
amino acid sequence remained unchanged compared to M102. From 201 
mismatches investigated, 161 concerned the third position of the codon of the 
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targeted M102 ORF, and mostly were silent (n=152). The remaining 49 mismatches 
resulted in 30 amino acid changes.  
Of the 156 CRISPR2 spacers, 55 (35 %) showed sequence similarity  to M102 
(more than 22 identical residues; Fig. 2B), but none matched perfectly. Again, the 
majority of the mismatches were positioned at the third base of the codon (69 out of 
93 mismatches investigated). In total, only 18 amino acid changes resulted from 
these mismatches. 
 It had been shown previously that within a CRISPR repeat family 
bacteriophage derived sequences located adjacent to the proto-spacers, the region 
in the phage genome correspoding with the spacer, exhibit conservation (Bolotin et 
al., 2005; Deveau et al., 2008; Horvath et al., 2008b). In this study, comparison of the 
sequences adjacent to CRISPR1 proto-spacers showed conservation within the 
three-bases-stretch at the 3’ end (5’-WRR; Fig. 3A). Two sub-motifs were recognized 
in different strains. In OMZ 64, OMZ 382, OMZ 1040, OMZ 1079, OMZ 381 and 
MT4863 a 5’-WAAR-3’ motif is present (Fig. 3B), whereas the remaining strains show 
a 5’-WGG-3’ motif (Fig. 3C). In contrast, no conservation was observed next to the 5’ 
end of the proto-spacers (not shown).  
With regard to CRISPR2 the sequences 3’ to the CRISPR2 proto-spacers 
showed no conservation, whereas the three bases located at the 5’ site exhibited 
commonly the motif 5’-TTC-3’ (Fig. 3D).  
 
Similarity of CRISPR spacers to other sequences 
Apart from the evident sequence similarity to bacteriophage M102, some CRISPR1 
and CRISPR2 spacers showed similarity to other invading mobile elements, namely 
bacteriophages from other streptococci, plasmids and transposons (Supplementary 
Table S6). Three CRISPR1 and CRISPR2 spacer sequences showed similarity to a 
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48 kb plasmid present in three copies in the genome of Streptococcus agalactiae 
pNEM316-1 (Glaser et al., 2002). Some CRISPR2 spacers from OMZ 26, OMZ 27 
and OMZ 960 match the sequence of the genomic island Tnsmu1, which 
encompasses SMU.191c to SMU.221c and is present in UA159 and other S. mutans 
strains (Waterhouse et al., 2007). The clustering of spacers in OMZ 27 hints at 
repeated attacks of Tn1smu or at simultaneous incorporation of multiple spacers 
from the Tn1smu genome. Two CRISPR1 spacers matched the ORFs SMU.1705 
and SMU.820 of S. mutans UA159. 
 
Analysis of CRISPR1 in M102-resistant mutants 
Spontaneous mutants of OMZ 381 resistant to infection by M102 could easily be 
isolated. PCR analysis showed that in 14 of 57 analyzed mutants the size of the 
CRISPR array had increased by approximately the size of one spacer and one 
repeat (Table 2). The acquisition of a novel spacer and repeat in these mutants was 
confirmed by DNA sequencing. In OMZ 432, a strain isolated from a rat whose oral 
cavity had been inoculated with the wild-type strain (OMZ 381) and then challenged 
with phage M102, two additional CRISPR1 spacers were detected (Table 2) 
With one exception (OMZ 381-M5) all newly acquired spacers and repeats 
became inserted proximal to the CRISPR1 leader. This corroborates results from 
previous studies with phage resistant S. thermophilus mutants (Barrangou et al., 
2007; Deveau et al., 2008). In all but one case (OMZ 381-M71), the novel spacer 
sequences matched the genome sequence of M102 perfectly. In OMZ 381-M71 one 
mismatch at the ultimate 5’ base of the proto-spacer is present. In some mutants, 
nearly identical spacers are incorporated (Table 2).  
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In mutants M3, M60 and M71 the spacer matched the same phage sequence, 
but the length of the spacer differed. This was also found for two other mutants (OMZ 
432 and M56). The region 3’ to the proto-spacer sequence exhibited a conserved 
motif (YAAAWY), which is similar to the CRISPR1 motif described above (Fig. 3B). 
Bacteriophage M101 is related to phage M102 (van der Ploeg, 2007). It was 
therefore investigated whether the M102-resistant mutants were also resistant 
against phage M101. The results showed that only mutants M60 and M71 were 
sensitive to M101 infection (Table 2). In these mutants, the acquired CRISPR1 
spacer is homologous to a sequence of M102. However, this sequence is also 
present in the CRISPR1 spacer in mutant M3, which was resistant to infection by 
M101. To determine whether the differences in sensitivity to phage infection were 
related to differences in the proto-spacers, their sequences were determined. Some 
of the proto-spacer sequences in M101 were identical to those in M102 (M3, M60 
and M62), whereas others were different. In fact the proto-spacer in M101 differed 
from the novel spacer in mutant M5 by as many as 7 nucleotides. Although M5 is 
resistant to infection by M101, it is hard to conceive that the acquired spacer in this 
mutant could provide protection. It has previously been reported that mutation of only 
one nucleotide in the phage proto-spacer rendered S. thermophilus bacteriophage 
2972 unaffected to CRISPR-mediated resistance (Deveau et al., 2008). 
 
Inactivation of SMU.1405c or CRISPR1 is insufficient to render sensitivity for 
infection by the bacteriophage 
In order to try to confirm that resistance to phage M102 is conferred by the CRISPR1 
system, mutants in the cas5 gene SMU.1405c were constructed in OMZ 67, OMZ 
961, OMZ 1001, OMZ 381-M3, and OMZ 381-M46. However, all resulting mutants 
remained resistant to infection by phage M102 (data not shown). Next, the CRISPR1 
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clusters of OMZ 7, OMZ 67, OMZ 1001, OMZ 381-M3 and OMZ 381-HS were 
deleted and replaced by an erythromycin resistance cassette. These mutants 
remained also resistant to infection by phage M102 (not shown). 
 
 
Discussion 
The results of this study show that mutants of strain OMZ 381, which have 
become resistant to bacteriophage M102, have acquired novel CRISPR1 spacers 
that are most likely derived from the phage genomic DNA since their sequence 
matches the genome sequence of M102. This finding is in agreement with studies 
with phage resistant mutants of S. thermophilus (Barrangou et al., 2007; Horvath et 
al., 2008b). However, just as remarkable is the fact that in the majority of the M102 
resistant OMZ 381 mutants no change in the CRISPR1 cluster had occurred. Thus, it 
is evident that in S. mutans there must exist other CRISPR1/2 independent and not 
yet identified mechanism(s) for acquired immunity to phage infection. In line with this 
conclusion are two further observations: 1st, inactivation of the CRISPR1 cluster in 
several different S. mutans strains and in a phage-resistant mutant of OMZ 381 with 
an acquired supplementary CRISPR1 spacer, did not re-establish sensitivity to M102 
infection; 2nd, some of the novel M102-resistant mutants were also resistant to 
infection by M101, although there was only partial homology between the novel 
spacer sequence and the proto-spacer of M101. One possible explanation is that 
many S. mutans strains (other than UA159), may carry further, still unknown CRISPR 
cluster(s) with CRISPR-associated genes. In fact, some S. thermophilus strains 
possess three different CRISPR arrays (Horvath et al., 2008b). Whole genomic 
sequencing of other S. mutans strains may reveal whether one or more additional 
CRISPR clusters exist. 
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This study demonstrates that the prevalence, the composition and the 
sequence of CRISPR1 and CRISPR2 in S. mutans are highly variable. The 
polymorphic nature of CRISPR makes the two clusters useful markers for 
epidemiologic studies. CRISPR1 was found to occur more frequently than CRISPR2. 
Although the choice of primers and or PCR conditions might have an influence on the 
results, the distribution frequency is congruent with results from a comparative 
genomic hybridization study (Waterhouse et al., 2007). In that study, it was shown 
that a complete set of CRISPR1-associated genes (SMU.1405 to SMU.1400) was 
present in seven of nine strains investigated. Of these nine strains, seven were also 
part of the present work (GS5, At10, L18, LML5, LML7, MT4863 and MT4653) and in 
all but LML5 a CRISPR1 array was found. LML5 has been reported previously to lack 
CRISPR1-associated genes (Waterhouse et al., 2007) and indeed, no CRISPR1 
array could be detected. With respect to CRISPR2, however, a complete set of 
CRISPR2-associated genes (SMU.1764 to SMU.1753) and a CRISPR2 array were 
only present in a single strain, GS5 (OMZ 67). These results agree with previous 
observations that particular CRISPR repeat clusters are functionally coupled with 
particular CAS subtypes (Horvath et al., 2008b; Kunin et al., 2007).  
My comparison of the sequences of cas1 and csd1 from strain UA159 with 
those from other strains and species suggests that both genes are non-functional in 
UA159. It has been speculated that Cas1 functions to integrate novel spacers into 
CRISPR2 (Makarova et al., 2006). Hence, UA159 should have lost the ability to do 
so, and this would fit with the here described observation that UA159 contains only a 
single CRISPR2 spacer. This hypothesis is also consistent with the observation that 
in E. coli the Cas1 protein was found dispensable for resistance to infection by 
phage λ (Brouns et al., 2008). 
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About half of the CRISPR1 and CRISPR2 spacers exhibited similarity to the 
genome of phage M102. It has previously been shown for S. thermophilus that a 
correlation exists between resistance to phage infection and the number of spacers 
with sequence similarity to phage sequences (Bolotin et al., 2005). In the present 
study, only one pair consisting of an infecting phage (M102) and a receptive strain 
(OMZ 381) was available for investigation. This limited material does not allow 
drawing conclusions about the relationship between CRISPR content and phage 
resistance. But the high prevalence of M102 homologous spacer sequences among 
S. mutans strains suggests that S. mutans is frequently exposed to M102-like 
phages. Interestingly, most mismatches between homologous spacers and the M102 
phage sequence affected the third base of the codon. This indicates that many 
different variants of M102 may exist and possibly evade CRISPR-mediated 
resistance through silent or conservative mutations without affecting the function of 
phage-encoded proteins. Such a mechanism has been proposed for S. thermophilus, 
where a single base pair change in the phage genome was sufficient for escaping 
resistance caused by the CRISPR machinery (Barrangou et al., 2007; Deveau et al., 
2008). This could represent a major driving force for the evolution of bacteriophage 
mutants. 
Plasmids occur in about 5 % of all S. mutans strains (Caufield et al., 1988). 
However, none of the CRISPR1 or CRISPR2 spacers showed sequence similarity to 
the previously identified S. mutans plasmids pLM7 and pUA140 (Zhou et al., 2001). 
This is surprising, since spacers with similarity to a plasmid from S. agalactiae were 
present in some strains. Equally unexpected, though not unprecedented, was the 
finding that two CRISPR1 spacers matched ORFs present in the S. mutans UA159 
genome. There are no indications that these ORFs are located on genomic islands or 
are part of prophage sequences. It is hence not clear why spacers derived from 
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these ORFs were incorporated. Speculatively, one could postulate that the CRISPR 
machinery occasionally confounds host DNA or host mRNA with invading nucleic 
acids and erroneously attacks the former. Alternatively, uptake of homologous 
chromosomal DNA of lysed S. mutans cells during natural competence might 
provoke capture of novel spacers.  
In summary, this study demonstrates high degree of variability in the 
sequences of CRISPR1 and CRISPR2 in S. mutans. A large fraction of CRISPR1 
and CRISPR2 spacers have homology to M102, suggesting that the organism often 
encounters M102-like phages. Although the presented data indicate that acquired 
resistance to M102 infection cannot be explained by the function of the two identified 
CRISPR clusters alone, the emergence of phage resistant mutants following 
exposure to M102, as observed experimentally in vivo in a rat model, seems to be a 
rather frequent event. 
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 Table 1:  Strains of S. mutans used in this study 1 
Strain 
Original 
designation 
Sero- 
type 
presence of 
CRISPR1* 
presence of 
CRISPR2* Origin  
Reference or source 
OMZ  7 NCTC 10449† c 3 7 UK (Edwardsson, 1968) 
OMZ  20 MT118 c 33 -‡ Japan (Hamada & Ooshima, 1975) 
OMZ  25 MT142 c 18 - Japan (Hamada & Ooshima, 1975) 
OMZ 26 C67-1 c - 6 The Netherlands (de Stoppelaar et al., 1971) 
OMZ 27 C67-25 c - 50 The Netherlands (de Stoppelaar et al., 1971) 
OMZ 30 MT12 c - 42 Japan (Hamada & Ooshima, 1975) 
OMZ 64 IB1600 c 12 - Sweden (Krasse, 1966) 
OMZ 67 GS-5 c 22 2 USA (Gibbons et al., 1966) 
OMZ 70 ATCC 33535 § c - - Switzerland (Guggenheim, 1968) 
OMZ 186 KPSK2 = JC2 c 5 - Sweden (Carlsson, 1967) 
OMZ 380 P34 c 8 - France G. Tiraby, Toulouse 
OMZ 381 P42 c 6 - France G. Tiraby, Toulouse 
OMZ 382 S61 c 31 - France G. Tiraby, Toulouse 
 27
OMZ 737 R9 c - - UK D. J. Bradshaw, Salisbury 
OMZ 918 UA159 c 6 1 USA ATCC 
OMZ 949 “NG8” c 5 -  D. Cvitkovitch, Toronto 
OMZ 960 UA130 c - 13 USA G. Spatafora, Middlebury 
OMZ 961 “NG8” c 5 -  G. Spatafora, Middlebury 
OMZ 1040 PK1 c 20 - USA (Gibbons et al., 1966) 
OMZ 1079  c 38 - Switzerland J. R. van der Ploeg, unpublished results 
At10  c 6 - Sweden (Edwardsson, 1968) 
L18  c 15 - Finland (Grönroos & Alaluusua, 2000) 
LML5  c - - UK (Waterhouse & Russell, 2006) 
LML7  c 9 - UK (Waterhouse & Russell, 2006) 
MT4863  c 6 - Japan (Hamada et al., 1980) 
OMZ 125 LM7 e 26 - USA  (Gibbons et al., 1966) 
MT4653  e 16 - Japan (Hamada et al., 1980) 
OMZ 175  f - 1 Switzerland (Guggenheim, 1968) 
OM98x  k 25 33 Japan T. Sato, Tokyo 
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* the number of spacers is shown 1 
† NCTC, National Collection of Type Cultures 2 
‡ -, None detected 3 
§ ATCC, American Type Culture Collection 4 
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Table 2: M102-resistant mutants of OMZ 381 
 
mutant novel spacer sequence size 
(bp) 
M102 
coordinates * 
5' seq† 3' seq‡ sensitivity 
to  M101§ 
M101 proto-spacer¶ 
OMZ432 AGGAAATCTCCTTACACGCTTAGCAAGTGT 30 21421-21450 AACAGAAAAG TAAATGCTAG - AGGAAATCTCCTTACACGCTTAGCAAGCAT 
OMZ432 AAGATGGCTGAAGAGACCGGGGTTAACGCC 30 12228-12198 (r) TACCATTTCC TAAATTAGCA - AAGATGGCTGAAGAGACCGGGGTTAACGCC 
OMZ 381-HS TGACAGCAATTTTTACACTGGCACAGTAGC 30 21301-21330 ATGTAGGTGA TAAATTTATG - TGATAGCAACCTCTACACCGGAACAGTAGC 
OMZ 381-M3 ATATGTAATAGGTCATAATGATGATGGCAC 30 17268-17297 TTGCCCGTGA TAAAACAATT - ATATGTAATAGGTCATAATGATGATGGCAC 
OMZ 381-M5 GCAGTCAGTAGCGCAACAAGAGCTACAGGC 30 16560-16579 TTGCAGACGC TAAAGCAAGT - ACAATCAGTCGCACAACAAGAACTGCAAGC 
OMZ 381-M19 TATGCGTTGGATTGTTTTTGCTCTGTCTA 29 21869-21841 (r) TAGCACCGAT TAAAGCCTTC - TGTGCGTTGAATTGTCTTTGCTCTGTCTA 
OMZ 381-M46 TCATTTCTCCTGCATTTTATTAGTAACTAG 30 21687-21658 (r) ACCTCTATTT TAAATTATGC - TCCTTTCTCCTGCATTTTATTAGGCGCTAG 
OMZ 381-M51 TAGCAAACGGAGCTTTGCTGTATAGAGCCCTT 32 1463-1432 (r) TTAGCAACTT AAAGTTGAAG - TAGCAAACGGAGCTTTGCTGTATAGAACCCTT 
OMZ 381-M54 GATAATGCTTTTGCCAAAGCACAGCTAATC 30 4621-4650 CGACGTTATC CAAAACGCTT - GATAATGTTTTTGCTAAAGCGCAGTTAATC 
OMZ 381-M56 CAAGATGGCTGAAGAGACCGGGGTTAACGCC  31 12228-12198 (r) TTACCATTTC TAAATTAGCT - CAAGATGGCTGAAGAGACCGGGGTTAACGCC 
OMZ 381-M60 AATATGTAATAGGTCATAATGATGATGGCAC  31 17267-17297 TTTGCCCGTG TAAAACAATT + AATATGTAATAGGTCATAATGATGATGGCAC 
OMZ 381-M62 TAAGAATTTGTTTTCTTTGGCATTCAGCCA  30 1993-1964 (r) CTTTCAATTC CAAATTCAAG - TAAGAATTTGTTTTCTTTGGCATTCAGCCA  
OMZ 381-M63 GTGGCAAAAGTGATAGCTAGGAACATGCCT  30 9798-9827 AATCGAAGAT CAAATCATCA - nd# 
OMZ 381-M69 AAAGAGGAATACAAAGACCCGAATACTTGGA 31 1808-1838 CAAGATGATA TAAAGTCTAA - AAAGAGGAATACAAAGACCCGAATACTTGGA 
OMZ 381-M71 CATATGTAATAGGTCATAATGATGATGGCAC  31 17267-17297 TTTGCCCGTG TAAAACAATT + AATATGTAATAGGTCATAATGATGATGGCAC  
 
*  coordinates of M102 proto-spacer. (r), reverse strand. 
† sequence 5’ to the M102 proto-spacer 
‡ sequence 3’ to the M102 proto-spacer 
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§ +, sensitive; -, resistant to infection by phage M101 
¶ Proto-spacer sequence of M101. Underlined residues are different from the corresponding proto-spacer of M102 
# nd, not determined 
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Legend to figures 
 
Fig. 1:  
Organization of CRISPR1 (A) and CRISPR2 (B) arrays and associated genes in 
S. mutans UA159. Lines below the Orf numbers show the size the gene would have 
when frame shift or stop codons (see text) would be removed. CRISPR spacers are 
shown by boxes (black, conserved; white, degenerated). Repeats are shown by 
diamonds. 
 
Fig. 2:  
Analysis of CRISPR1 (A) and CRISPR2 (B) in S. mutans. Repeats are shown as 
lines; the last non-conserved repeat is shown as dashed line. Spacers are 
represented by diamonds; shading indicates similarity to known sequences. Spacers 
that are encircled have identical sequences; spacers that are surrounded by a 
rectangle show similarity to sequences different from the genome of phage M102.   
 
Fig. 3:  
Weblogo motifs of sequences 5’ and 3’ to proto-spacers.  A, Sequences located 
3’ to CRISPR1 proto-spacers; B, sequences 3’ to CRISPR1 proto-spacers targeted 
by spacers from strains OMZ 64, OMZ 382, OMZ 1040, OMZ 1079 and OMZ 381;  C, 
sequences 3’ to CRISPR1 proto-spacers targeted by spacers from strains OMZ 20, 
OMZ 25, OMZ 67, OMZ 186, OMZ 380, OMZ 382, UA159, AT10, L18, LML7, 
Mt4863, OMZ 125, Mt4653 and OM98x;  D, sequences 5’ to CRISPR2 proto-spacers. 
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Figure 2A 
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Figure 2B
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